IKT Hisse Senedi Fiyat Grafiği
IKT Kâr Dağıtımı
Inhibikase Therapeutics Inc
$2.33
-3.31%
$-0.08
Kapanışta: Sep 10, 16:00:00 GMT-4
$2.33
0%
$0
Sonrası Piyasa: Sep 10, 20:00:00 GMT-4
Geri
Inhibikase Therapeutics Inc (IKT) Kâr Dağıtımı
Önemli İstatistikler
Önceki Kapanış
$2.41
Açılış fiyatı
$2.37
Günün Aralığı
$2.32 - $2.37
52 haftalık aralık
$1.33 - $2.61
İşlem hacmi
332.3K
Ort.Hacim
737.2K
Dividend yield
--
EPS (TTM)
-0.50
Piyasa Değeri
$365.8M
IKT nedir?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
